Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 37 most recent Form 4 transactions.
| PCVX |
| Vaxcyte, Inc. |
| FTAX |
| 2,862 |
| $60.74 |
| $173.8K |
| -0.6% |
| Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 16,198 | — | — | — | Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | SSELL◷ | 378 | $55.91 | $21.1K | -0.3% | Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | SSELL◷ | 622 | $55.54 | $34.5K | -0.5% | Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | SSELL◷ | 244 | $55.96 | $13.7K | -0.2% | Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | SSELL◷ | 756 | $55.52 | $42K | -0.6% | Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | SSELL◷ | 4,415 | $55.93 | $246.9K | -1.0% | Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | SSELL◷ | 11,783 | $55.52 | $654.1K | -2.5% | Open the original filing on SEC.gov |
| Jul 27 | PCVX | Vaxcyte, Inc. | MEXER◷ | 16,198 | $2.03 | $32.9K | +3.6% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 191 | $56.27 | $10.7K | -0.1% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 602 | $55.30 | $33.3K | -0.4% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 207 | $54.22 | $11.2K | -0.1% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 332 | $55.99 | $18.6K | -0.3% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 356 | $55.23 | $19.7K | -0.3% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 312 | $54.35 | $17K | -0.2% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 6,417 | $56.12 | $360.1K | -1.4% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 9,137 | $55.27 | $505K | -1.9% | Open the original filing on SEC.gov |
| Jun 26 | PCVX | Vaxcyte, Inc. | SSELL◷ | 6,683 | $54.28 | $362.7K | -1.4% | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 225 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | SSELL◷ | 1,000 | $52.50 | $52.5K | -0.7% | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | SSELL◷ | 1,000 | $52.50 | $52.5K | -0.7% | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | SSELL◷ | 22,236 | $52.50 | $1.2M | -4.5% | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | SSELL◷ | 225 | $52.51 | $11.8K | <0.1% | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | MEXER◷ | 225 | $1.79 | $403 | +<0.1% | Open the original filing on SEC.gov |
| Mar 9 | PCVX | Vaxcyte, Inc. | FTAX | 3,685 | $59.32 | $218.6K | -0.7% | Open the original filing on SEC.gov |
| Mar 2 | PCVX | Vaxcyte, Inc. | FTAX | 2,531 | $61.98 | $156.9K | -0.5% | Open the original filing on SEC.gov |
| Feb 28 | PCVX | Vaxcyte, Inc. | FTAX | 2,863 | $61.98 | $177.4K | -0.6% | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT◆ | 175,698 | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT | 105,110 | — | — | +26.2% | Open the original filing on SEC.gov |
| Jan 14 | PCVX | Vaxcyte, Inc. | GGIFT | 100,000 | — | — | -20.0% | Open the original filing on SEC.gov |
| Sep 8, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 7,356 | $32.41 | $238.4K | -1.5% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 3,420 | $31.56 | $107.9K | -0.7% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 4,563 | $31.56 | $144K | -0.9% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 2,857 | $31.56 | $90.2K | -0.5% | Open the original filing on SEC.gov |
| May 30, 2025 | ATHA | Athira Pharma, Inc. | AGRANT◆ | 20,900 | — | — | — | Open the original filing on SEC.gov |